Steven A. Stacker

Active 1984–2023

78
Papers
20,159
Citations
72
h-index
78
i10-index

Citations

Citations per year for Steven A. Stacker1987: 2 citations1988: 1 citations1990: 11 citations1991: 26 citations1992: 87 citations1993: 78 citations1994: 69 citations1995: 60 citations1996: 62 citations1997: 63 citations1998: 90 citations1999: 112 citations2000: 121 citations2001: 201 citations2002: 271 citations2003: 280 citations2004: 274 citations2005: 290 citations2006: 286 citations2007: 207 citations2008: 268 citations2009: 242 citations2010: 181 citations2011: 198 citations2012: 166 citations2013: 155 citations2014: 152 citations2015: 139 citations2016: 130 citations2017: 131 citations2018: 172 citations2019: 483 citations2020: 493 citations2021: 509 citations2022: 311 citations2023: 242 citations2024: 333 citations2025: 125 citations2026: 5 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,047 citing papers, 29.4% of this breakdownChina: 677 citing papers, 9.7% of this breakdownUnited Kingdom: 438 citing papers, 6.3% of this breakdownGermany: 388 citing papers, 5.6% of this breakdownJapan: 360 citing papers, 5.2% of this breakdownAustralia: 348 citing papers, 5% of this breakdownFinland: 277 citing papers, 4% of this breakdownSwitzerland: 231 citing papers, 3.3% of this breakdownItaly: 196 citing papers, 2.8% of this breakdownNetherlands: 189 citing papers, 2.7% of this breakdownCanada: 184 citing papers, 2.7% of this breakdownFrance: 173 citing papers, 2.5% of this breakdown
0%29.4%Other 20.8%

Fields

  • Medicine52.6%
  • Biochemistry, Genetics and Molecular Biology31.3%
  • Immunology and Microbiology7.8%
  • Neuroscience3.9%
  • Engineering1.7%
  • Materials Science0.7%
  • Other2%

Topics

  • Angiogenesis and VEGF in Cancer9.3%
  • Lymphatic System and Diseases8.7%
  • Cell Adhesion Molecules Research4%
  • Cancer, Hypoxia, and Metabolism2.1%
  • Cancer Cells and Metastasis1.9%
  • Axon Guidance and Neuronal Signaling1.7%
  • Other72.3%

Coauthors

All papers

Open in search
  1. Lymphangiogenesis and lymphatic vessel remodelling in cancer

    Authors: , , , , , - Nature reviews. Cancer 2014 cited by 823

  2. Consensus guidelines for the use and interpretation of angiogenesis assays

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Napoleone Ferrara, Marcus Fruttiger, Dai Fukumura, Bart Ghesquière, Yan Gong, Robert J. Griffin, Adrian L. Harris, Christopher C.W. Hughes, Nan W. Hultgren, M. Luisa Iruela‐Arispe, Melita Irving, Rakesh K. Jain, Raghu Kalluri, Joanna Kalucka, Robert S. Kerbel, Jan Kitajewski, Ingeborg Klaassen, Hynda K. Kleinmann, Pieter Koolwijk, Elisabeth Kuczynski, Brenda R. Kwak, Koen M. Marien, Juan M. Melero‐Martin, Lance L. Munn, Roberto F. Nicosia, Agnès Noël, Jussi Nurro, Anna-Karin Olsson, Tatiana V. Petrova, Kristian Pietras, Роберто Пили, Jeffrey W. Pollard, Mark J. Post, Paul H.A. Quax, Gabriel A. Rabinovich, Marius Raica, Anna M. Randi, Doménico Ribatti, Curzio Rüegg, Reinier O. Schlingemann, Stefan Schulte‐Merker, Lois E. H. Smith, Jonathan W. Song, Steven A. Stacker, Jimmy Stalin, Amber N. Stratman, Maureen Van de Velde, Victor W.M. van Hinsbergh, Peter Vermeulen, Johannes Waltenberger, Brant M. Weinstein, Hong Xin, Bahar Yetkin-Arik, Seppo Ylä‐Herttuala, Mervin C. Yöder, Arjan W. Griffioen - Angiogenesis 2018 cited by 597

  3. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 350

  4. The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment

    Authors: , , , , , - Frontiers in Immunology 2016 cited by 191

  5. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3

    Authors: , , , , , , , , , , , , - The EMBO Journal 2001 cited by 850

  6. Sox18 induces development of the lymphatic vasculature in mice

    Authors: , , , , , , , , , , , , , , , , , - Nature 2008 cited by 568

  7. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 1,208

  8. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

    Authors: , , , , , , , , , - Nature Medicine 2001 cited by 1,249

  9. Vascular remodeling in cancer

    Authors: , , , - Oncogene 2013 cited by 197

  10. VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium

    Authors: , , , , , , , , , , , , , , , , - Cancer Cell 2012 cited by 275

  11. YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells

    Authors: , , , , , , , , , , , , - Nature Communications 2023 cited by 37

  12. VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses

    Authors: , , , , , , , , , , , - Circulation Research 2003 cited by 445

  13. Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System

    Authors: , , , , , , , , - Molecular and Cellular Biology 2005 cited by 291

  14. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis

    Authors: , , , , , , , , , , , - Development 2014 cited by 178

  15. Emerging Roles for VEGF-D in Human Disease

    Authors: , - Biomolecules 2018 cited by 165

  16. The Interplay Between Lymphatic Vessels and Chemokines

    Authors: , , , , - Frontiers in Immunology 2019 cited by 73

  17. Lymphangiogenesis and cancer metastasis

    Authors: , , , , - Nature reviews. Cancer 2002 cited by 797

  18. The Wnt Coreceptor Ryk Regulates Wnt/Planar Cell Polarity by Modulating the Degradation of the Core Planar Cell Polarity Component Vangl2

    Authors: , , , , , , , , - Journal of Biological Chemistry 2012 cited by 133

  19. Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development

    Authors: , , , , , , - Development 2017 cited by 89

  20. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).

    Authors: , , , , , , - The Journal of Cell Biology 1990 cited by 891

  21. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease

    Authors: , , , , , , , - Cell 1995 cited by 707

  22. Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse Embryos

    Authors: , , , , , , , , - Molecular and Cellular Biology 2008 cited by 195

  23. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2005 cited by 545

  24. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

    Authors: , , , , , , , , , - Diabetes 1999 cited by 476